CELEX: 62017TA0821
Language: en
Date: 2018-12-12 00:00:00
Title: Case T-821/17: Judgment of the General Court of 12 December 2018 — Vitromed v EUIPO — Vitromed Healthcare (VITROMED Germany) (EU trade mark — Opposition proceedings — Application for EU figurative mark VITROMED Germany — Earlier EU word mark Vitromed — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

4.3.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 82/53
            
         
      Judgment of the General Court of 12 December 2018 — Vitromed v EUIPO — Vitromed Healthcare (VITROMED Germany)
      (Case T-821/17) (1)
      
      ((EU trade mark - Opposition proceedings - Application for EU figurative mark VITROMED Germany - Earlier EU word mark Vitromed - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001)))
      (2019/C 82/63)
      Language of the case: German
      
         Parties
      
      
         Applicant: Vitromed GmbH (Jena, Germany) (represented by: M. Linß, lawyer)
      
         Defendant: European Union Intellectual Property Office (represented by: A. Graul, D. Walicka and M. Fischer, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Vitromed Healthcare (Jaipur, India) (represented by: J. Schmidt, lawyer)
      
         Re:
      
      Action brought against the decision of the Second Board of Appeal of EUIPO of 26 September 2017 (Case R 2402/2016-2) relating to opposition proceedings between Vitromed Healthcare and Vitromed.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Vitromed GmbH to pay the costs.
               
            
         (1)  OJ C 52, 12.2.2018.